Histologic grading system for prostate cancer based on microscopic tumor architecture patterns. Uses primary and secondary tumor patterns to predict prognosis and guide treatment decisions. The score combines the two most prevalent architectural patterns found in the tumor specimen.
Awaiting Clinical Input
Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.
The Gleason Score for Prostate Cancer is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within urology.
Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.
Well-differentiated, favorable prognosis
Moderately differentiated, intermediate prognosis
Poorly differentiated, unfavorable prognosis
Very poorly differentiated, very unfavorable prognosis
Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.
Open in Web AppClinical Decision Support (CDS) Notice & Legal Disclaimer
This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.